Workshop of the joint working group “Adaptive Designs and Multiple Testing Procedures” of the German Region (DR) and the Basel Biometric Section (BBS) of the Austro-Swiss (ROeS) Region of the International Biometric Society (IBS) PDF

Novartis Learning Center Horburg, Müllheimerstrasse 195, 4057 Basel, Switzerland (Map of the workshop venue PDF).

This BBS meeting is scheduled for Tuesday 4 February 2014 16:00-17:30.
Location: Auditorium of the Roche Learning Center, Aeschenvorstadt 56, 4051 Basel

Willi Sauerbrei, Patrick Royston, Benjamin Kasenda and Matthias Briel, A method for IPD meta-analysis of treatment-covariate interaction with a continuous predictor in randomised trials

Actelion Pharmaceuticals, Hegenheimermattweg 95, 4123 Allschwil (direction PDF, building map GIF).

Willi Sauerbrei and Patrick Royston, Towards stratified medicine – instead of dichotomization, estimate a treatment effect function for a continuous covariate
Willi Sauerbrei and Patrick Royston, A new strategy for meta-analysis of continuous covariates in observational studies with IPD

Health Technology Assessment – Joint BBS/EFSPI Seminar Flyer PDF
Health Technology Assessment – Joint BBS/EFSPI Seminar Program PDF
Health Technology Assessment – Joint BBS/EFSPI Seminar Summary PDF

Actelion Pharmaceuticals, Hegenheimermattweg 91, 4123 Allschwil (direction PDF, building map GIF).

European Statistical Meeting Health Technology Assessment
Fred Sorenson, Health Technology Assessment – Why is it so important?
Matthias Egger and Mike Chambers, Moving HTA forward: The challenges of incorporating real world evidence into Health Technology Assessment
Mike Chambers and Matthias Egger, GetReal: Clinical effectiveness in drug development
Claudia Nicolay, Health Technology Assessment – What’s in for Stats?
Jens Grüger, HTA and personalized healthcare
Skip Olson, HTA – Use of observational, retrospective or prospective studies
Bruno Falissard, The place of subjectivity in the French system (HAS): a good thing or an archaism?
Ralf Bender, Biometrical topics of Health Technology Assessment in Germany
Friedhelm Leverkus, 30 Months AMNOG Health Technology Assessment: Outcomes and Issues
Lou Garrison, HTA in Emerging Markets: A Framework and Examples
Richard Nixon, Using early health economic models to support drug development decisions
Chrissie Fletcher, Using indirect treatment comparisons to support an HTA

Wednesday 28th November 9:00–12:30 at Actelion Pharmaceuticals, Hegenheimermattweg 91, 4123 Allschwil (direction PDF, building map GIF).

Agenda BBS Seminar Optimal Design for Non-linear Models PDF

Agenda BBS Seminar Emerging Topics in Pharmaceutical Statistics PDF

Stephen A. Julious, Sample sizes for multiple must-win trials
Eric Derobert, A parameterized strategy of gatekeeping, keeping untouched the probability of having at least one significant result
Lisa Hampson, Group sequential tests for delayed responses

Agenda BBS Seminar Experiences in the Development and Implementation of Flexible Designs PDF

Agenda BBS Seminar PDF